Karl Storz launches surgical education tech for Apple Vision Pro

With the CollaboratOR 3D app for Apple Vision Pro, surgical staff can immerse themselves in 3D content from surgical procedures without entering the OR. [Image courtesy of Karl Storz]Karl Storz announced that it released the CollaboratOR 3D app for Apple Vision Pro to provide immersive surgical education.

This marks yet another medtech application on Apple’s VR headset, with Siemens Healthineers and Stryker recently unveiling similar offerings.

Karl Storz designed its application in tandem with software developer T1V to complement the functionality of OR1, an integrated operating room solution. The company said it identified a need to improve the educational experience and collaboration opportunities for surgeons. This includes new surgical residents and practicing surgeons across a wide range of specialties.

CollaboratOR 3D allows surgical staff to immerse themselves in 3D content from surgical procedures without entering the OR. It can both enhance …

Read more
  • 0

Asensus, Karl Storz partner on surgical robot marketing, development

The Intelligent Surgical Unit powers the Senhance surgical robot system. [Image courtesy of Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that it entered into a memorandum of understanding with Karl Storz VentureONE.

Karl Storz VentureOne is a wholly-owned subsidiary of Karl Storz SE, a maker of endoscopes and other medical instruments and devices. The family-owned company closely collaborates with surgeons and healthcare partners around the globe on technologies for minimally invasive procedures.

The agreement between the surgical robot maker and Karl Storz includes plans for marketing and development. Research Triangle Park, North Carolina-based Asensus develops the Senhance surgical robot platform. It also develops the Intelligent Surgical Unit (ISU) for Senhance.

Asensus designed ISU as a real-time intraoperative surgical image analytics platform. It leverages augmented intelligence to help reduce surgical variability. Earlier this week,…

Read more
  • 0

FDA flags infection risk from reusable urological endoscopes

The FDA said today that is looking into the causes of infections from reprocessed urological endoscopes based on “numerous” adverse event reports.

The agency said that since 2017 it has received more than 450 medical device reports — including three deaths — associated with reprocessed cystoscopes, ureteroscopes and cystourethroscopes used for viewing and accessing the urinary tract. The reports describe post-procedure infections or “other possible contamination issues” associated with cleaning and disinfecting the devices.

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0